Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells

Alantolactone (Ala), a major sesquiterpene lactone extracted from Inula helenium, exerts potent anti-tumour activities in various cancers. However, the underlying mechanism of such activities is still ambiguous. This study focused on evaluating the anti-tumour effects and molecular mechanisms of Ala...

Full description

Bibliographic Details
Main Authors: Xing Kang, Hijuan Wang, Yanwei Li, Ying Xiao, Lili Zhao, Tingting Zhang, Shaohe Zhou, Xiaolun Zhou, Yi Li, Zhexing Shou, Chao Chen, Bin Li
Format: Article
Language:English
Published: Taylor & Francis Group 2019-12-01
Series:Artificial Cells, Nanomedicine, and Biotechnology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21691401.2019.1593854
_version_ 1818008691957301248
author Xing Kang
Hijuan Wang
Yanwei Li
Ying Xiao
Lili Zhao
Tingting Zhang
Shaohe Zhou
Xiaolun Zhou
Yi Li
Zhexing Shou
Chao Chen
Bin Li
author_facet Xing Kang
Hijuan Wang
Yanwei Li
Ying Xiao
Lili Zhao
Tingting Zhang
Shaohe Zhou
Xiaolun Zhou
Yi Li
Zhexing Shou
Chao Chen
Bin Li
author_sort Xing Kang
collection DOAJ
description Alantolactone (Ala), a major sesquiterpene lactone extracted from Inula helenium, exerts potent anti-tumour activities in various cancers. However, the underlying mechanism of such activities is still ambiguous. This study focused on evaluating the anti-tumour effects and molecular mechanisms of Ala on HepG2 cells. Our results demonstrated that Ala might inhibit cellular proliferation, induce G2/M phase arrest and apoptosis in HepG2 cells. Specifically, this study confirmed that Ala induced G2/M phase arrest by upregulating p21, downregulating cyclin A1 and cyclin B1, and promoting cellular apoptosis by increasing the expression of cleaved caspase-3 and PARP. Furthermore, Ala caused an increase in reactive oxygen species (ROS) level and inhibition of ROS production significantly prevented Ala-induced apoptosis. Interestingly, the accumulation of ROS, in turn, suppressed the downstream AKT signalling. Finally, mitophagy of Ala-treated HepG2 cells was observed by Mito/Lyso staining. Mitophagy was significantly inhibited by downregulation of the expression of PINK1 and Parkin proteins. The inhibition of mitophagy by a mitophagy inhibitor was found to markedly enhance Ala-mediated apoptosis and growth inhibition in HepG2 cells. Consequently, Ala induced cellular apoptosis via ROS-mediated suppression of AKT signalling and inhibition of PINK1-mediated mitophagy. Thus, Ala has potential to be used for the treatment of liver cancer.
first_indexed 2024-04-14T05:33:36Z
format Article
id doaj.art-1f85074b3e1a4b68861b7707bc711464
institution Directory Open Access Journal
issn 2169-1401
2169-141X
language English
last_indexed 2024-04-14T05:33:36Z
publishDate 2019-12-01
publisher Taylor & Francis Group
record_format Article
series Artificial Cells, Nanomedicine, and Biotechnology
spelling doaj.art-1f85074b3e1a4b68861b7707bc7114642022-12-22T02:09:44ZengTaylor & Francis GroupArtificial Cells, Nanomedicine, and Biotechnology2169-14012169-141X2019-12-014711961197010.1080/21691401.2019.1593854Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cellsXing Kang0Hijuan Wang1Yanwei Li2Ying Xiao3Lili Zhao4Tingting Zhang5Shaohe Zhou6Xiaolun Zhou7Yi Li8Zhexing Shou9Chao Chen10Bin Li11Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, PR ChinaKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, PR ChinaKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, PR ChinaKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, PR ChinaKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, PR ChinaKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, PR ChinaKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, PR ChinaDepartment of Pathogenic Biology, Gansu medical college, Pingliang, PR ChinaSchool of Computer Sciences, Xi’an Polytechnic University, Xi’an, PR ChinaDepartment of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR ChinaCollege of Life Science, National Engineering Research Center for Miniaturized Detection Systems, Northwest University, Xi’an, PR ChinaKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, PR ChinaAlantolactone (Ala), a major sesquiterpene lactone extracted from Inula helenium, exerts potent anti-tumour activities in various cancers. However, the underlying mechanism of such activities is still ambiguous. This study focused on evaluating the anti-tumour effects and molecular mechanisms of Ala on HepG2 cells. Our results demonstrated that Ala might inhibit cellular proliferation, induce G2/M phase arrest and apoptosis in HepG2 cells. Specifically, this study confirmed that Ala induced G2/M phase arrest by upregulating p21, downregulating cyclin A1 and cyclin B1, and promoting cellular apoptosis by increasing the expression of cleaved caspase-3 and PARP. Furthermore, Ala caused an increase in reactive oxygen species (ROS) level and inhibition of ROS production significantly prevented Ala-induced apoptosis. Interestingly, the accumulation of ROS, in turn, suppressed the downstream AKT signalling. Finally, mitophagy of Ala-treated HepG2 cells was observed by Mito/Lyso staining. Mitophagy was significantly inhibited by downregulation of the expression of PINK1 and Parkin proteins. The inhibition of mitophagy by a mitophagy inhibitor was found to markedly enhance Ala-mediated apoptosis and growth inhibition in HepG2 cells. Consequently, Ala induced cellular apoptosis via ROS-mediated suppression of AKT signalling and inhibition of PINK1-mediated mitophagy. Thus, Ala has potential to be used for the treatment of liver cancer.https://www.tandfonline.com/doi/10.1080/21691401.2019.1593854AlantolactoneapoptosisROSmitophagyAKT
spellingShingle Xing Kang
Hijuan Wang
Yanwei Li
Ying Xiao
Lili Zhao
Tingting Zhang
Shaohe Zhou
Xiaolun Zhou
Yi Li
Zhexing Shou
Chao Chen
Bin Li
Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells
Artificial Cells, Nanomedicine, and Biotechnology
Alantolactone
apoptosis
ROS
mitophagy
AKT
title Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells
title_full Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells
title_fullStr Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells
title_full_unstemmed Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells
title_short Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells
title_sort alantolactone induces apoptosis through ros mediated akt pathway and inhibition of pink1 mediated mitophagy in human hepg2 cells
topic Alantolactone
apoptosis
ROS
mitophagy
AKT
url https://www.tandfonline.com/doi/10.1080/21691401.2019.1593854
work_keys_str_mv AT xingkang alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT hijuanwang alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT yanweili alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT yingxiao alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT lilizhao alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT tingtingzhang alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT shaohezhou alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT xiaolunzhou alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT yili alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT zhexingshou alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT chaochen alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells
AT binli alantolactoneinducesapoptosisthroughrosmediatedaktpathwayandinhibitionofpink1mediatedmitophagyinhumanhepg2cells